Uncover early signals of drug risks and prevent patient harm
December 5, 2022
Ingest and process data from the FDA database
To better discover patterns and detect potential safety signals in adverse drug reactions, quickly upload, process, clean, and filter standard data files from the FDA Adverse Event Reporting System (FAERS). With Dataiku, data ingestion is automated, standardized, and audit-ready.
Detect drug risks early and prevent patient harm
Easily process complex raw data and filter on demographic, drug, reaction, and report characteristics. Get analysis-ready signal surveillance and immediate insights into adverse drug reactions — helping teams act faster to protect patients.
Improve statistical inference and signal detection
Calculate common disproportionality metrics including relative odds ratios (ROR), proportional reporting ratio (PRR), and empirical Bayes geometric mean (EBGM) to understand the strength of drug-reaction associations and prioritize safety signals for review.
Explore the solution metric dashboard
Monitor and triage potential safety signals
Identify and visualize patterns in your safety data with the solution's descriptive analytics and charts. Get a complete picture of complex patterns and potential safety signals — making it easier to triage, prioritize, and act.
See safety report signals in action
Ensure patient safety and increase regulatory compliance
Filter reports, generate cohort signals, and run drug/reaction analysis to detect dangerous interactions or drug misuse and discover potential off-label treatment for new diseases — all within a fully auditable, compliance-ready environment.
Explore disproportionality analysis in Dataiku
Turn insights into alerts
Gather signals from spontaneous reporting systems, set analytics-based alerts and easily push the resulting elements into case management systems for investigation.
Check out the safety reports analytics dashboard
Answer key pharmacovigilance questions
The Dataiku Solution for Pharmacovigilance helps answer a broad range of questions — from which drugs are associated with the highest adverse event rates, to how signals compare across demographic groups, to where regulatory reporting obligations may apply.
Read the documentation on Pharmacovigilance
Go from advanced insights to intelligent process automation
With Dataiku, enhancing safety surveillance practices is just a starting point: quickly move from one use case to another, leveraging reusable datasets and components across the platform to build an end-to-end intelligent pharmacovigilance pipeline.
